XRHealth offering is now closed and is no longer accepting investments.

On-demand virtual care reinvented

INVEST IN XRHEALTH TODAY!

XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.
... Show more
This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
XRHealth

Reasons to Invest

  • The metaverse global market opportunity is projected to reach 800 billion by 2024 and the fast-growth telehealth market is predicted to reach a value of $70.19 billion by 2026XRHealth has already contributed significantly to this projection. In 2021, XRHealth generated over $1M of this revenue in YTD and our QoQ growth has been 300+%.
  • XRHealth was operating clinics in the metaverse before there was a common word to describe the next evolution of the internet or web 3.0. To date, XRHealth has treated over 2,000 patients in 5 virtual clinics. XRHealth plans to be a central player in DTx technology (aka Digital Therapeutics) using virtual and augmented reality to offer therapy in the metaverse.
  • XRHealth is poised to be an industry leader in VR/AR therapy due to strict adherence to FDA and HIPPA regulations during the past 5 years. XRHealth currently has 3 approved patents, 8 FDA registered medical applications, and 6 3rd party apps already in use. The digital services are covered by insurance thanks to changes in CPT codes during the pandemic, making it one of the most trustworthy digital health services.

Overview


Bringing Patient Care Into the Metaverse

XRHealth is spearheading the VR/AR therapy revolution by combining proprietary FDA-registered medical virtual reality (VR/AR) therapy with conventional telehealth solutions to offer patients personalized care they need for chronic conditions in the metaverse.

1:1 Virtual Therapy With Virtual Reality

From the Comfort of Home



A comprehensive therapeutic at-home care solution for multiple chronic conditions:


Our Virtual Therapy is Safe, Secure and Loved by Our Patients:



We also offer Software as a Service (Saas) to providers, hospitals, and rehabilitation centers.

Our Story




XRHealth was founded by Eran Orr, an Air Force veteran pilot and an industry early adopter of virtual reality (VR). After suffering from chronic neck pain caused by heavy helmets used during flights, he saw a need to bring his VR expertise into healthcare. Based on his experience, he believed VR was the perfect tool for simulated training to maximize the effectiveness of physical therapy.


So...he set on a new mission to help others recover from pain by using VR. He teamed up with interdisciplinary experts including medical professionals, data scientists, graphic artists, and more to make it happen. XRHealth became the first company to combine a telehealth online clinic with gamified virtual reality facilitated by licensed therapists.

The Problem


Current Telehealth Technology Provides Limited Treatment

1. Chronic conditions affect 60% of Americans, with more than 40% experiencing 2 or more conditions. Some conditions may require long waits to receive care to heavy patient loads in clinics.


2. Despite the need for ongoing care, patients are often over-taxed due to 'commuter fatigue,' pain of care, or boredom. As a result, patients have a 50% average treatment adherence rate and 70% churn rate (in comparison with 91.2% adherence and 10% churn with XRHealth).


3. Digital at-home services became the 'new normal,' which highlighted the gaps in brick and mortar care including the lack of data, real-time progress insights, easy-to-use platforms and interfaces, access to clinicians outside of therapy, and more.


Source 1Source 2, Source 3

THE Market


A Fast Growing Industry With Impact Across Healthcare Verticals 

The fast-growth telehealth market is projected to grow to $70.19 billion by 2026 and the metaverse global market is expected to climb to 800 billion by 2024. Telehealth services doubled during the pandemic and is expected to be the 'new normal' as lifestyles adjust and digital services improve.


The pandemic doubled the number of people who have used telehealth from 39.4% pre-COVID-19 to 79.5% post-quarantine. 



Our services meet the specific needs of the following patient markets:



Our services meet the specific needs of the following patient markets: 



The Solution


Building Therapy in the Metaverse

  • Our platform combines immersive VR/AR technology with telehealth services, licensed clinicians, and advanced data analytics for an all-in-one innovative solution for patients to receive high-quality care in the comfort of their homes via the Metaverse (the new term used to describe the virtual world).
  • We provide our patients with enjoyable treatments that feel like less work and more fun. Patients participate in weekly sessions with a licensed therapist who guides and monitors their treatment in real-time and adjusts therapy protocols remotely in the VR/AR headset.
  • In between sessions, the patient practices virtual reality exercises according to the tailored VR digital treatment plan (in addition to conventional exercises that may be suggested).
  • Patients use our mobile app to track their own progress, chat with their therapist, and communicate easily with clinic staff.
  • After each therapy session, the patient's insurance company is billed for telehealth services and Remote Therapeutic Monitoring (RTM) (a newly introduced CPT code now used to support the growth of digital therapeutics and foster the development of remote patient services).




Virtual Worlds, Real Results

Patients enjoy therapeutic exercises that feel more like games than work to promote adherence to treatment. Patients and therapists gain instant progress insights from biofeedback and other data-tracking mechanisms that flows from the headset to the XRHealth platform. Therapists can use this data to personalize treatments for optimal success.





XRHealth takes digital health services to the web 3.0 revolution in the metaverse 


In the old world, you needed to drive to a clinic or hospital and go to a specific room to meet with a therapist who is often chosen by the clinical setting or HMO plan. But the way we are conducting therapy is rapidly changing to match the modern lifestyle.


In the metaverse, you can enter any virtual treatment room and meet any therapist you want (or meet other patients) no matter where they are. And we believe this fosters better compliance with treatment, which we are already seeing from primary surveys.


That's why we are building some of the first virtual clinics in the metaverse. 

This is the new world:

  1. Quantified data
  2. Real-time progress analysis
  3. Accessibility to care
  4. Improved patient experience


Gamified therapy fosters better treatment compliance because its fun! 





Better Results = Better Quality of Life 

XRHealth patients across multiple health verticals report a decrease in symptoms related to chronic pain, stress & anxiety, and neurological conditions.


Pain Management vertical:



Behavioral Health vertical:



Neurological Disorders vertical:


Business Model


Our GO TO MARKET Strategy Combines:



B2C: Direct to Consumer



Our Insurance Coverage



B2B: SaaS - Virtual Treatment Rooms

In our B2B model, inpatient and outpatient facilities partner with XRHealth to expand their skilled therapy and rehabilitation services. We generate revenue throughout the process. 




Our Partner Providers


The Patient's Voice




"It's better to have 100 users love you than 1 million [sic] kinda like you. The true seed of scale is love, and you can't buy it, hack it, or game it", said Sam Altman, Master of scale.


Our Growth


Growth on all fronts 


The XRhealth platform expansion drives growth! To date, XRHealth has treated over 2,000 patients in 5 operating virtual clinics. 


Therapy in the metaverse is no longer a dream or science fiction. It's already working, making it clear that the new reality of healthcare is in immersive, digital applications.


Let's take a look at the numbers. XR Health is expanding exponentially to meet the growing demand, with a current growth rate of 400%.


*The above graphic includes unaudited financial information and is subject to change. From Q1-Q3 2021, the Company has achieved $1.1M in revenue. The Company is pending their final Q4 unaudited data. Please refer to the risk factors in our Form C regarding forward looking information and our financial information.



Future Growth Plan

The use of funds is focused on

(1) Clinic expansion

(2) RnD - platform expansion


Insert Image
Drop image
(or click)

Loading image

ABOUT

HEADQUARTERS
1330 Beacon St STE 209
Brookline, MA 02446
VALUATION
$80.97M

XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.

TEAM

Eran Orr

Eran Orr

CEO, Founder & Director

During a 15-year career as an F-16 fighter pilot in the Israeli Air Force and several executive positions, Eran has established himself as a worldwide leader in the XR and health industries and is an official Forbes Councils Member.

Gilad Meiri

Gilad Meiri

Board of Directors

Gilad is a serial entrepreneur and active angel investor. He currently acts as a board member and the CFO of Cupixel. Before that Gilad founded and was the CEO of Neura (acquired by Otonomo Technologies) and Spicebox Labs. Gilad is also a director in publicly traded Third Eye Systems (TASE: THES).

Miki Levy

Miki Levy

CTO & Co-Founder

During a 16-year career as an executive officer in the Israeli Air Force Miki received the IDF Major General's Award of Excellence. Miki serves as the president of the VR/AR Association, Tel Aviv chapter.

Deepa Javeri

Deepa Javeri

Chief Financial Officer

During a 15-year career in financial services ranging from equity portfolio management at Merrill Lynch to M&A banking at Morgan Stanley, Deepa developed broad expertise in capital markets, financial planning, and corporate strategy.

Gal Hayut

Gal Hayut

Board of Directors

After more than 13 years at the Venture Capital Industry and 4 years as the Managing Director of The Portland Trust Israel, a nonprofit 'action-tank" that leads economic development projects in the undeserved population in Israel, Gal recently established Bridges Israel, together with his two partners. Bridges Israel an impact investments fund that invest in businesses that operate among the underserved population in Israel as well as in "tech-for good" Start-ups

Sergey Gribov

Sergey Gribov

Board of Directors

Technology entrepreneur and investor with more than 20 years of experience. Sergey has a lot of experience across such sectors as software development, VoIP, cybersecurity, digital health, finance, and others. Today Sergey is an investor, board member, or mentor in several startups across US and Israel. Sergey holds an MBA, Sloan Fellow from MIT and B.Sc. in Computer Science, Cum Laude from Beer-Sheva University.

Hillel Bachrach

Hillel Bachrach

Board of Directors

Entrepreneur with more than 40 years of experience managing and funding the commercial global introduction of innovative and revolutionary medical and life science technologies. After a successful career as an entrepreneur starting many companies that were either sold or went public, in 2005 Hillel founded 20/20 HealthCare Partners, an investment company where he is the Managing Partner.

TERMS

XRHealth
Overview
PRICE PER SHARE
$25.63
DEADLINE
Feb 9, 2022
VALUATION
$80.97M
AMOUNT RAISED
$255,146.53
Breakdown
MIN INVESTMENT
$256.30
MAX INVESTMENT
$106,979.62
MIN NUMBER OF SHARES OFFERED
390
OFFERING TYPE
Equity
ASSET TYPE
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
41,746

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

XRHealth, Inc.

Corporate Address

:

1330 Beacon St STE 209, Brookline, MA 02446

Offering Minimum

:

$9,995.70

Offering Maximum

:

$1,069,949.98

Minimum Investment Amount

(per investor)

:

$256.30











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

390

Maximum Number of Shares Offered

:

41,746

Price per Share

:

$25.63

Pre-Money Valuation

:

$80,974,114.87











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Early Bird

Early Bird Bonus - First 7 days | XRHealth t-shirt

Volume

Tier 1 perk ($256) - Limited edition merchandise for investors only: XRHealth T-shirt)

Tier 2 perk ($512) - Limited edition merchandise for investors only: XRHealth signature coin)

Tier 3 perk ($1,500) - Limited edition merchandise for investors only: XRHealth stress ball + signature coin + T-shirt)

Tier 4 perk ($3,000) - Exclusive webinar with Eran Orr, XRHealth CEO, "Overview about Healthcare and XR") 

Tier 5 perk ($5,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps)

Tier 6 perk ($10,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps + 1:1 meeting with Eran Orr, XRHealth CEO, on Zoom) 

*All perks occur when the offering is completed.

Irregular Use of Proceeds

We will not incur any irregular use of proceeds.

PRESS

Article Image
VR Focus

VRHealth To Make Its Medical Platform Available For Use At Home

Article Image
Times Magazine

The Coronavirus Outbreak Could Finally Make Telemedicine Mainstream in the U.S.

Article Image
Rachel Ray Show

Medical Virtual Reality featured on the Rachael Ray Show.

Article Image
MobiHealth News

VRHealth, AARP launch VR platform for remote patient monitoring, in-home therapy

Article Image
BBC

How virtual reality can help you manage pain










ALL UPDATES

02.06.22

48 Hours Left to Invest! Don't miss this opportunity to change the face of healthcare.

Let's face it. Our world is changing right before our eyes as technology advances. And this is a big deal to healthcare. Now, we are on the brink of a massive healthcare revolution. The impending model is more:

  • Personalized
  • Digital
  • Interactive
  • Data-centric
  • Convenient
  • and most of all, fun. 

What would you like to add to the list?  

We welcome you to not just have a seat at the table, but to have a voice at it too! You have 48 hours left to invest in the future of healthcare. Don't miss out!

02.01.22

One week left! Don't miss out on the opportunity of a lifetime.


The campaign is winding down. And we'd hate to see you miss out. If you've been following the tech or healthcare news, healthcare is changing thanks to budding new technology and the improvements of existing tech. If you want to be part of making big waves in healthcare, now's your chance!

Invest in the next big thing in healthtech. Invest in the metaverse.

01.31.22

We're in Nasdaq!

We might be biased, but the market isn't. See what the big players are saying about us in Nasdaq.

01.19.22

We've been featured in Tech Crunch!

[Image: LG Nova]


Nothing quite makes it all feel real like seeing XRHealth in Tech Crunch!


Read how we've been shortlisted for LG Nova's incubator here!

01.18.22

The Consumer Electronics Show (CES) was a hit!

We started this year with a bang! XRHealth took our proof-of-concept to Las Vegas at one of the most noteworthy electronics trade shows in the world.

Check out our pics from the show, where we revealed our proof-of-concept for our LG Nova proto challenge contest (which we won). Treatment rooms in the metaverse in assisted living and continuing care retirement communities are on their way!


Nothing kicks off the day quite like a mimosa. 


Eran Orr with a captive audience


Eran test-driving our booth.


It's a game. It's therapy. It's a treatment room in the metaverse. 




01.13.22

The 30 Day Countdown Has Begun

Thanks for supporting XRHealth on our amazing journey. The last 30 days of our first crowdfunding campaign is winding down on Start Engine.

We wanted to make sure you don't miss out on this incredible opportunity to be part of building the future of healthcare.

We have been working diligently to address chronic conditions via VR/AR technology for the past two years and now we are ready to scale up. And with your contribution, we can help millions of people thrive despite their chronic conditions.

It's been an amazing crowdfunding journey. And now this round is coming to an end. 

At the time of writing this post, we’ve already raised over $200K on this round alone. On top of this, we've developed new partnerships that are bound to send us into the new year with an extra boost. And there is still room for you!

Are you ready to join in the mission to take these achievements one step further as we spread nationally and globally?

01.12.22

Just a little chat with one of the world's biggest players in extended reality

If you're not excited about VR/AR in the Metaverse yet, listen to our founder and CEO, Eran Orr, speak about our therapeutic applications with HTC VIVE. And check out exciting visuals! Who knew this would be the future of treatment. 


01.06.22

Introducing XRHealth Treatment Rooms with HTC’s VIVE Focus 3 and VIVE Flow


XRHealth has just teamed up with HTC, the global leader in premium virtual reality (VR). HTC is paving the way for businesses to use VR technology. With our partnership, this now means they can step up their game with treatment rooms in the Metaverse.

Clinicians will be able to use VIVE Focus 3, preloaded with XRHealth’s applications, to create a virtual treatment center that will engage and treat patients remotely.

VIVE Focus 3 will help amp up the therapy with high-quality visuals, a replaceable long-lasting battery, and an ultra-wide 120-degree field of view. Now, it’ll be even easier to feel part of the virtual world.

Patients can also enter their virtual treatment rooms from the comfort of their homes (or anywhere they have internet) using the ultra-lightweight VIVE Flow accessible with an Android 5G smartphone! And feel like they are transported to other worlds with their "VR colored" sunglasses, making VR feel more accessible to those just stepping into the Metaverse. 

With options like this, patients are bound to feel motivated to complete their exercises. Because who wouldn’t want to chase dragons or sit by the virtual seaside instead of doing the same old, boring routines?

01.04.22

XRHealth and LG Nova have teamed up to pilot treatment rooms in the metaverse in assisted living and continuing care retirement communities


It's a great honor to announce that we're among a handful of socially impactful startups accepted into LG NOVA’s Proto Challenge, their preliminary startup competition designed to coincide with LG NOVA’s global challenge program, Mission for the Future, to find technological solutions that will contribute to a better life. LG is allocating more than $1 million in initial funding to selected winning companies from LG NOVA Proto Challenge.

 

As part of the program, we will be piloting virtual treatment rooms in assisted living and continuing care retirement facilities to foster quality remote care using our VR/AR technology. We will be showcasing our proof-of-concept at the Consumer Electronics Show (CES) in Las Vegas on January 5-7, 2022. 


“What better forum than CES – the most influential tech event in the world – to celebrate the startups and entrepreneur communities building solutions to some of the world’s most pressing issues,” said LG NOVA Head Dr. Sokwoo Rhee, Corporate Senior Vice President for Innovation at LG Electronics. “As our LG NOVA program progresses, we’re using the power of collaboration to fuel innovation for society overall.”



What a way to kick-off the new year! Wishing all of you a meaningful, healthy year and years to come. 

12.28.21

The Metaverse Won Christmas!

If you're wondering what tech trends to follow, you can always get a glimpse of what tops the charts after Christmas. Well, this year, CNBC writer, Steve Koach, revealed that the Oculus VR app was the most popular app in Apple's App Store on Christmas Day.  For those of you not following 'techie' news, Meta (Facebook), acquired Oculus back in 2014, anticipating the next big tech boom with virtual reality. Fast-forward to the present and they are proving themselves seers in the Web 3.0 revolution. 

According to Koach, the app topping the charts indicates that Oculus VR headsets were among the most popular gifts this year. Because why would you download an app without the headset, right? This is also a sign of this year's tech trends. This may be the first year that Meta's Oculus app lead the way, but it is indubitably the last. 

Oculus might not stay at the top, but this chart supports the theory that the public is getting ready to adopt metaverse technology.

Are you ready to step into the Metaverse? Or help build it? 











REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into XRHealth.

$256.00

Tier 1 perk

($256) - Limited edition merchandise for investors only: XRHealth T-shirt)

$512.00

Tier 2 perk

($512) - Limited edition merchandise for investors only: XRHealth signature coin)

$1,500.00

Tier 3 perk

($1,500) - Limited edition merchandise for investors only: XRHealth stress ball + signature coin + T-shirt)

$3,000.00

Tier 4 perk

($3,000) - Exclusive webinar with Eran Orr, XRHealth CEO, "Overview about Healthcare and XR")

$5,000.00

Tier 5 perk

($5,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps)

$10,000.00

Tier 6 perk

($10,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps + 1:1 meeting with Eran Orr, XRHealth CEO, on Zoom)

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDSWe want you to succeed and get the most out of your money by offering rewards and memberships!
SECUREYour info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTSInvest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.